Judith C Yang
Judith C Yang
Verified email at pitt.edu
Cited by
Cited by
The ATLAS experiment at the CERN large hadron collider
G Aad, JM Butterworth, J Thion, U Bratzler, PN Ratoff, RB Nickerson, ...
Jinst 3, S08003, 2008
A randomized trial of bevacizumab, an anti–vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang, L Haworth, RM Sherry, P Hwu, DJ Schwartzentruber, ...
New England Journal of Medicine 349 (5), 427-434, 2003
Cancer regression in patients after transfer of genetically engineered lymphocytes
RA Morgan, ME Dudley, JR Wunderlich, MS Hughes, JC Yang, ...
Science 314 (5796), 126-129, 2006
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
EK Speliotes, CJ Willer, SI Berndt, KL Monda, G Thorleifsson, AU Jackson, ...
Nature genetics 42 (11), 937-948, 2010
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma
SA Rosenberg, BS Packard, PM Aebersold, D Solomon, SL Topalian, ...
New England Journal of Medicine 319 (25), 1676-1680, 1988
Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer
L Gandhi, D Rodríguez-Abreu, S Gadgeel, E Esteban, E Felip, ...
New England Journal of Medicine 378 (22), 2078-2092, 2018
10 years of GWAS discovery: biology, function, and translation
PM Visscher, NR Wray, Q Zhang, P Sklar, MI McCarthy, MA Brown, ...
The American Journal of Human Genetics 101 (1), 5-22, 2017
Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy
TR Mackie, T Holmes, S Swerdloff, P Reckwerdt, JO Deasy, J Yang, ...
Medical physics 20 (6), 1709-1719, 1993
Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.
SA Rosenberg, MT Lotze, JC Yang, PM Aebersold, WM Linehan, ...
Annals of surgery 210 (4), 474, 1989
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2
SA Rosenberg, JR Yannelli, JC Yang, SL Topalian, DJ Schwartzentruber, ...
JNCI: Journal of the National Cancer Institute 86 (15), 1159-1166, 1994
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
CJ Langer, SM Gadgeel, H Borghaei, VA Papadimitrakopoulou, A Patnaik, ...
The lancet oncology 17 (11), 1497-1508, 2016
Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
IM Heid, AU Jackson, JC Randall, TW Winkler, L Qi, V Steinthorsdottir, ...
Nature genetics 42 (11), 949-960, 2010
Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study
SHI Ou, JS Ahn, L De Petris, R Govindan, JCH Yang, B Hughes, H Lena, ...
Journal of clinical oncology 34 (7), 661-668, 2016
Pitfalls of predicting complex traits from SNPs
NR Wray, J Yang, BJ Hayes, AL Price, ME Goddard, PM Visscher
Nature Reviews Genetics 14 (7), 507-515, 2013
Highly selective plasma-activated copper catalysts for carbon dioxide reduction to ethylene
H Mistry, AS Varela, CS Bonifacio, I Zegkinoglou, I Sinev, YW Choi, ...
Nature communications 7 (1), 1-9, 2016
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3 …
JCH Yang, LV Sequist, SL Geater, CM Tsai, TSK Mok, M Schuler, ...
The lancet oncology 16 (7), 830-838, 2015
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg, RM Sherry, KE Morton, WJ Scharfman, JC Yang, ...
The Journal of Immunology 175 (9), 6169-6176, 2005
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
A Cortes, J Hadler, JP Pointon, PC Robinson, T Karaderi, P Leo, ...
Nature genetics 45 (7), 730, 2013
High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
HJ Zeh, D Perry-Lalley, ME Dudley, SA Rosenberg, JC Yang
The Journal of Immunology 162 (2), 989-994, 1999
Shape-dependent catalytic properties of Pt nanoparticles
S Mostafa, F Behafarid, JR Croy, LK Ono, L Li, JC Yang, AI Frenkel, ...
Journal of the American Chemical Society 132 (44), 15714-15719, 2010
The system can't perform the operation now. Try again later.
Articles 1–20